Pearls in Anticoagulation Management for Patients With Left Ventricular Assist Devices

Overview

Journal Tex Heart Inst J

Specialty Cardiology & Vascular Diseases

Date 2023 Jul 17

PMID 37459421

Authors

Ellen Yin

Affiliations

Soon will be listed here.

Citing Articles

Survival of a patient following initial left ventricular assist device implantation and two successive left ventricular assist device exchanges: case report.

Scarsella L, Bentley A, Amer M, Thal S Eur Heart J Case Rep. 2024; 8(12):ytae618.

PMID: 39669551 PMC: 11635636. DOI: 10.1093/ehjcr/ytae618.

References

Damman K, van den Broek S, Mecozzi G, Droogh J, Metz E, Oude Lansink A . Conservative initial postoperative anticoagulation strategy after HeartMate 3 left ventricular assist device implantation. Neth Heart J. 2022; 30(10):466-472. PMC: 9475015. DOI: 10.1007/s12471-022-01671-1. View

Jennings D, Rimsans J, Connors J . Prothrombin Complex Concentrate for Warfarin Reversal in Patients with Continuous-Flow Left Ventricular Assist Devices: A Narrative Review. ASAIO J. 2019; 66(5):482-488. DOI: 10.1097/MAT.0000000000001021. View

Andreas M, Moayedifar R, Wieselthaler G, Wolzt M, Riebandt J, Haberl T . Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial. Circ Heart Fail. 2017; 10(5). PMC: 5434960. DOI: 10.1161/CIRCHEARTFAILURE.116.003709. View

Parikh V, Parikh U, Moctezuma-Ramirez A, Lamba H, George J, Fedson S . Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices. Gen Thorac Cardiovasc Surg. 2020; 68(11):1278-1284. DOI: 10.1007/s11748-020-01371-w. View

Loyaga-Rendon R, Kazui T, Acharya D . Antiplatelet and anticoagulation strategies for left ventricular assist devices. Ann Transl Med. 2021; 9(6):521. PMC: 8039667. DOI: 10.21037/atm-20-4849. View